CSIMarket
 


Anixa Biosciences Inc   (ANIX)
Other Ticker:  
 
 

ANIX's Revenue Growth by Quarter and Year

Anixa Biosciences Inc 's Revenue results by quarter and year




ANIX Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter October 0.51 0.00 0.00 0.00
III Quarter July 0.00 0.00 0.00 0.00
II Quarter April 0.00 0.00 0.00 0.25
I Quarter January 0.00 0.51 0.00 0.00
FY   0.51 0.51 0.00 0.25



ANIX Revenue forth quarter 2022 Y/Y Growth Comment
Anixa Biosciences Inc in the forth quarter 2022 achieved Revenue of $ 0.51 millions compare to recorded in same quarter a year ago.

According to the results reported in the forth quarter 2022, Anixa Biosciences Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Anixa Biosciences Inc ' s Revenue no change of % ranks overall at the positon no. 0 in the forth quarter 2022.




ANIX Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -66.67 %
I Quarter January - - - -
FY   0.49 % - - -77.48 %

Financial Statements
Anixa Biosciences Inc 's forth quarter 2022 Revenue $ 0.51 millions ANIX's Income Statement
Anixa Biosciences Inc 's forth quarter 2021 Revenue $ 0.00 millions Quarterly ANIX's Income Statement
New: More ANIX's historic Revenue Growth >>


ANIX Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY (Year on Year)   0.49 % - - -77.48 %




Revenue forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0

Revenue Y/Y Growth Statistics
High Average Low
1.1258999068426E+16 % 5.629499534268E+14 % -100 %
(Oct 31 2016)   (Jan 31 2022)
Revenue forth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Y/Y Growth Statistics
High Average Low
1.1258999068426E+16 % 5.629499534268E+14 % -100 %
(Oct 31 2016)   (Jan 31 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Anixa Biosciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
564.36 % 14.04 % -100 %
(Jan 31 2015)  


ANIX's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #0
Revenue Q/Q Growth Statistics
High Average Low
564.36 % 14.04 % -100 %
(Jan 31 2015)  


ANIX's IV. Quarter Q/Q Revenue Comment


Anixa Biosciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Oct 31 2022)
12 Months Ending
(Jul 31 2022)
12 Months Ending
(Apr 30 2022)
12 Months Ending
(Jan 31 2022)
12 Months Ending
(Oct 31 2021)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Oct 31 2022 period, Anixa Biosciences Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Anixa Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Oct 31 2022 period, Anixa Biosciences Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Anixa Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ANIX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ANIX's Competitors
Revenue Growth for Anixa Biosciences Inc 's Suppliers
Revenue Growth for ANIX's Customers

You may also want to know
ANIX's Annual Growth Rates ANIX's Profitability Ratios ANIX's Asset Turnover Ratio ANIX's Dividend Growth
ANIX's Roe ANIX's Valuation Ratios ANIX's Financial Strength Ratios ANIX's Dividend Payout Ratio
ANIX's Roa ANIX's Inventory Turnover Ratio ANIX's Growth Rates ANIX's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Oct 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Oct 31 2022
Patterson Companies Inc -1.39%$ -1.392 millions
Medtronic Plc-3.34%$ -3.339 millions
National Vision Holdings Inc -3.63%$ -3.629 millions
Lakeland Industries Inc -5.48%$ -5.477 millions
The Cooper Companies Inc -5.82%$ -5.820 millions
Pfizer Inc-6.04%$ -6.043 millions
Enzo Biochem Inc -31.08%$ -31.083 millions
Perkinelmer Inc-38.99%$ -38.989 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CULP's Profile

Stock Price

CULP's Financials

Business Description

Fundamentals

Charts & Quotes

CULP's News

Suppliers

CULP's Competitors

Customers & Markets

Economic Indicators

CULP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071